Literature DB >> 10982155

Primary central nervous system lymphoma and subcutaneous metastases.

B Al Bahrani1, C Henderson, G Delaney.   

Abstract

Primary central nervous system lymphoma (PCNSL) is a rare disease with a poor prognosis. It usually remains confined to central nervous system (CNS). Reports of metastases outside of the CNS are rare. We report a patient with well-documented PCNSL who responded to treatment, but subsequently developed a histologically confirmed subcutaneous metastasis to the left leg without local failure.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10982155     DOI： 10.1023/a:1006458206558

Source DB:  PubMed          Journal:  J Neurooncol        ISSN： 0167-594X            Impact factor:   4.130


  18 in total

1.  Clinical presentation and therapeutic outcome in 26 patients with primary CNS lymphoma.

Authors:  U Herrlinger; M Schabet; M Clemens; R D Kortmann; D Petersen; B E Will; R Meyermann; J Dichgans
Journal:  Acta Neurol Scand       Date:  1998-04       Impact factor: 3.209

2.  Prognostic factors in the diagnosis and treatment of primary central nervous system lymphoma.

Authors:  I F Pollack; L D Lunsford; J C Flickinger; H L Dameshek
Journal:  Cancer       Date:  1989-03-01       Impact factor: 6.860

3.  Primary malignant lymphomas of the central nervous system.

Authors:  J M Henry; R R Heffner; S H Dillard; K M Earle; R L Davis
Journal:  Cancer       Date:  1974-10       Impact factor: 6.860

4.  Pathology with clinical correlations of primary central nervous system non-Hodgkin's lymphoma. The Massachusetts General Hospital experience 1958-1989.

Authors:  D C Miller; F H Hochberg; N L Harris; M L Gruber; D N Louis; H Cohen
Journal:  Cancer       Date:  1994-08-15       Impact factor: 6.860

Review 5.  Primary lymphoma of the central nervous system. Computerized tomography scan characteristics and treatment results for 12 cases.

Authors:  N P Mendenhall; T L Thar; O F Agee; B Harty-Golder; W E Ballinger; R R Million
Journal:  Cancer       Date:  1983-12-01       Impact factor: 6.860

6.  Radiation therapy in the management of primary malignant lymphoma of the brain.

Authors:  M P Berry; W J Simpson
Journal:  Int J Radiat Oncol Biol Phys       Date:  1981-01       Impact factor: 7.038

7.  Short intensive primary chemotherapy and radiotherapy in sporadic primary CNS lymphoma (PCL).

Authors:  M Brada; D Hjiyiannakis; F Hines; D Traish; S Ashley
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-03-15       Impact factor: 7.038

8.  Combined modality therapy for primary CNS lymphoma.

Authors:  L M DeAngelis; J Yahalom; H T Thaler; U Kher
Journal:  J Clin Oncol       Date:  1992-04       Impact factor: 44.544

Review 9.  Primary central nervous system lymphoma.

Authors:  F H Hochberg; D C Miller
Journal:  J Neurosurg       Date:  1988-06       Impact factor: 5.115

Review 10.  Primary central nervous system lymphoma with systemic metastasis: case report and review.

Authors:  M T Brown; R E McClendon; J P Gockerman
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130
View more
  2 in total

1.  Immunomodulatory effects of hemagglutinin- (HA-) modified A20 B-cell lymphoma expanded as a brain tumor on adoptively transferred HA-Specific CD4+ T cells.

Authors:  Valentin P Shichkin; Roman M Moriev
Journal:  ScientificWorldJournal       Date:  2014-02-16

2.  Unusual relapse of primary central nervous system lymphoma at site of lumbar puncture.

Authors:  Zartaj Ahmed; Ramesh K Ramanathan; Sunil Ram; James Newell; Maqbool Halepota
Journal:  Case Rep Hematol       Date:  2014-06-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.